108 related articles for article (PubMed ID: 15025737)
1. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years.
Pitsiu M; Hussein Z; Majid O; Aarons L; de Longueville M; Stockis A
Br J Clin Pharmacol; 2004 Apr; 57(4):402-11. PubMed ID: 15025737
[TBL] [Abstract][Full Text] [Related]
2. Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC study.
Hussein Z; Pitsiu M; Majid O; Aarons L; de Longueville M; Stockis A;
Br J Clin Pharmacol; 2005 Jan; 59(1):28-37. PubMed ID: 15606437
[TBL] [Abstract][Full Text] [Related]
3. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective.
Simons FE;
Pediatr Allergy Immunol; 2005 Mar; 16(2):97-103. PubMed ID: 15787865
[TBL] [Abstract][Full Text] [Related]
5. Clonidine disposition in children; a population analysis.
Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cetirizine in 2- to 6-year-old children.
Pariente-Khayat A; Rey E; Dubois MC; Vauzelle-Kervroedan F; Pons G; D'athis P; Murat II; Pinelli ME; Saint-Maurice C; Olive G
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):340-4. PubMed ID: 7582385
[TBL] [Abstract][Full Text] [Related]
7. Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years.
Simons FE; Simons KJ
J Allergy Clin Immunol; 2005 Aug; 116(2):355-61. PubMed ID: 16083790
[TBL] [Abstract][Full Text] [Related]
8. Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis.
Jullien V; Raïs A; Urien S; Dimet J; Delaugerre C; Bouillon-Pichault M; Rey E; Pons G; Blanche S; Tréluyer JM
Br J Clin Pharmacol; 2007 Jul; 64(1):105-9. PubMed ID: 17324223
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of oral busulfan in children.
Schiltmeyer B; Klingebiel T; Schwab M; Mürdter TE; Ritter CA; Jenke A; Ehninger G; Gruhn B; Würthwein G; Boos J; Hempel G
Cancer Chemother Pharmacol; 2003 Sep; 52(3):209-16. PubMed ID: 12811512
[TBL] [Abstract][Full Text] [Related]
10. The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride.
Krishna R; Krishnaswami S; Kittner B; Sankoh AJ; Jensen BK
Biopharm Drug Dispos; 2004 Dec; 25(9):373-87. PubMed ID: 15517550
[TBL] [Abstract][Full Text] [Related]
11. Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block.
Rapp HJ; Molnár V; Austin S; Krohn S; Gädeke V; Motsch J; Boos K; Williams DG; Gustafsson U; Huledal G; Larsson LE
Paediatr Anaesth; 2004 Sep; 14(9):724-32. PubMed ID: 15330953
[TBL] [Abstract][Full Text] [Related]
12. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
13. Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 years.
Jullien V; Urien S; Hirt D; Delaugerre C; Rey E; Teglas JP; Vaz P; Rouzioux C; Chaix ML; Macassa E; Firtion G; Pons G; Blanche S; Tréluyer JM
Antimicrob Agents Chemother; 2006 Nov; 50(11):3548-55. PubMed ID: 16940058
[TBL] [Abstract][Full Text] [Related]
14. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
Staatz CE; Tett SE
Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
[TBL] [Abstract][Full Text] [Related]
17. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine disposition in children: a population analysis.
Potts AL; Warman GR; Anderson BJ
Paediatr Anaesth; 2008 Aug; 18(8):722-30. PubMed ID: 18613931
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.
Blair EY; Rivory LP; Clarke SJ; McLachlan AJ
Br J Clin Pharmacol; 2004 Apr; 57(4):416-26. PubMed ID: 15025739
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
